healiva®
Edit

healiva®

https://www.healiva.com/
Last activity: 07.11.2023
Tags:BioTechCareHardwareHealthTechInsurTechLifeManagementMedTechPersonalTechnology
Healiva`s mission is to heal life, by offering a portfolio of innovative acute and chronic wound care solutions, which are personalized and affordable. Our approach combines enzyme technology, cell therapies and medical devices. We offer end-to-end offering of wound care solutions. Our multi-pronged approach to become the go-to-provider for all wound care needs – from wound debridement to treatment of severe wounds. 2-3% of the elderly suffer from painful venous/arterial leg ulcers and nearly 25% of diabetics may develop diabetic foot ulcers in their lifetimes. This figure set to rise with the increasing prevalence of contributing factors, including diabetes, advanced age, and obesity. This burden is also borne by healthcare systems, which spend 2% of their budgets on wound management. About ≈60% of chronic wounds remain unhealed. There remains a major gap in the current treatment paradigm. No permanent therapy for non-healing wounds currently exists. A successful regimen can prevent osteomyelitis, hospitalisation, amputation, and even death, allowing patients to re-establish their normal work/life routines. Healiva is targeting key pain-points in the patient care pathway. Our multifaceted customer base encompasses hospitals, medical practitioners, insurance providers and patients. We are developing a unique selling proposition for chronic wounds healing targeting the high cost of care, time to heal, requirements for frequent dressing changes and specialist medical expertise, whilst reducing wounds reoccurrence and accelerating patients’ re-establishment of normal work/life routines. Healiva’s portfolio potentially address the growing un-met need for chronic wound care, which forms part of the global €15.6B wound care market.
Mentions
10
Location: Switzerland, Ticino, Lugano
Employees: 1-10
Founded date: 2020

Investors 1

DateNameWebsite
09.11.2022VentureLabventurelab...

Mentions in press and media 10

DateTitleDescriptionSource
07.11.2023Healiva teams up with Japanese biotech to develop therapies ... Epidermolysis Bullosa (EB), also called. “butterfly children” disease is a genetic skin disorder c...startuptic...
06.11.2023A decent representation at BIO-Europe Attending events like BIO-Europe comes with several benefits for young companies. They will have t...startuptic...
14.12.2022Biotech start-up takes victory at Boldbrain Challenge The Boldbrain program has provided twenty selected innovative projects with an opportunity to deve...startuptic...
02.12.2022Boldbrain Startup Challenge announces finalists The fifth edition of the Boldbrain Startup Challenge is coming to an end. The acceleration program...startuptic...
21.11.2022Healiva Acquires Critical Cell Therapy Manufacturing Assets ...The acquisition will accelerate the launch of Healiva’s personalised skin regeneration therapy, EpiD...aithority....
21.11.2022Healiva acquires critical cell therapy manufacturing assets ... The acquired assets include a qualified cell bank, which is essential for the GMP-compliant manufa...startuptic...
05.09.202220 start-ups selected for Boldbrain Challenge The selection committee, composed of experts from different backgrounds, carefully examined all 67...startuptic...
21.07.2022Ten Biotech startups brace for Boston Boston is a hotspot for the biotech sector, boasting over 550 companies operating in the area. The...startuptic...
03.06.2022Healiva broadens its portfolio of wound-care therapies Founded in 2020 in Lugano by Bioseutica BV and Priyanka Dutta-Passecker, Healiva® is a patient-cen...startuptic...
23.05.2022Swiss Biotechs display their innovations at BIO 2022 Interna... After a successful online event last year – with over 6,000 participants from at least 55 countrie...startuptic...